Reporter
-
April 8, 2021
New Clinician Spotlight: Matthews Chacko
Matthews Chacko, MD, has joined Vanderbilt Heart and Vascular Institute as an assistant professor of Medicine, an interventional cardiologist and the director of peripheral vascular interventions. -
April 8, 2021
VUMC creates new Adult Post-acute COVID Clinic
On March 15, a new clinic opened at Vanderbilt University Medical Center, the Adult Post-acute COVID Clinic. With no single location, the clinic is a coordinated service across adult general medicine and medical specialty clinics, with a telemedicine component to facilitate initial patient assessments in most cases. -
April 8, 2021
Personalized Structural Biology aids cancer treatment decisions
Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural biologists across the Vanderbilt University campus, are taking “personalized” cancer therapy to a new level. -
April 7, 2021
New cardiac cath lab opens at Children’s Hospital
A new, state-of-the-art cardiac catheterization lab debuted recently at Monroe Carell Jr. Children’s Hospital at Vanderbilt to meet the growing volume of the Pediatric Heart Institute. -
April 7, 2021
Study revises understanding of cancer metabolism
Tumors consume glucose at high rates, but a team of Vanderbilt researchers has discovered that cancer cells themselves are not the culprit, upending models of cancer metabolism that have been developed and refined over the last 100 years. -
April 6, 2021
Vanderbilt mourns the passing of Pierre Massion
Pierre Massion, MD, Cornelius Vanderbilt Chair and Professor of Medicine, an internationally known expert on early detection and prevention strategies for lung cancer, died April 4 of an apparent heart attack. He was 58. -
April 6, 2021
U.S. government reserves supply of COVID-19 antibody cocktail discovered at VUMC
The U.S. government has reserved up to 700,000 doses of a monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca, officials have announced.